AcneCME ActivitiesJDD Webinars

Treating Acne in Adolescents and Young Adults

By February 23, 2021March 23rd, 2022No Comments

JDD Multimedia

Treating Acne in Adolescents and Young Adults

Featuring Leon H. Kircik, MD, Anthony J. Mancini, MD, FAAP, FAAD, Adelaide A. Hebert, MD

Join Drs. Leon H. Kirick, Anthony Mancini, and Adelaide Hebert, as they  explore the categorization and grading of acne by age of onset in children and adolescents. They will also review and discuss new and evolving acne treatment strategies that offer optimal outcomes in children and young adults presenting with acne.

Upon completion of this live, internet-based CE activity, participants should be able to:

  • Appreciate the updated pediatric care classification, including appropriate evaluations and treatment, when needed
  • Review acne treatment strategies offering optimal outcomes for pre-adolescents and adolescents with acne.

Faculty


Leon Kircik, MD
Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai, New York, NY
Indiana University Medical Center, Indianapolis, IN
Medical Director
Physicians Skin Care, PLLC, Louisville, KY
DermResearch, PLLC, Louisville, KY
Skin Sciences, PLLC, Louisville, KY


Anthony J. Mancini, MD, FAAP, FAAD
Head, Division of Dermatology, Ann & Robert H. Lurie Children’s Hospital of Chicago
Professor of Pediatrics and Dermatology, Northwestern University Feinberg School of Medicine
Chicago, Illinois

Adelaide A. Hebert, MD
Chief of Pediatric Dermatology
McGovern School of Medicine
Childrens’ Memorial Hermann Hospital
Houston, Texas

You May Also Like

Treating Acne in Adolescents and Young Adults

| Acne, CME Activities, JDD Webinars | No Comments
Join Drs. Leon H. Kirick, Anthony Mancini, and Adelaide Hebert, as they  explore the categorization and grading of acne by age of onset in children and adolescents. They will also…

Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update

| CME Activities | No Comments
1 CME CreditSince initial US Food and Drug Administration approval of botulinum toxin type A (BoNT-A) for aesthetic use in 2002, clinical evidence and experience with BoNT-A and understanding of…

What’s New in Topical Treatment for Actinic Keratosis

| CME Activities, JDD Webinars | No Comments
In this one-hour CME webinar, participants will learn the latest information on new topical therapeutic considerations for actinic keratosis, including the recently approved SrC kinase inhibitor. Upon completion of this…

Leave a Reply